SAme crew as GDLS ? anyone know ? SSP u there?
Tekron, Inc.
COMPANY DATA | INTRODUCTION | TEKRON, INC. SUBSIDIARY | MANAGEMENT
NEWS UPDATE | CHINESE
Address: 71 Sir James Court
Arva, Ontario
Canada N0M 1C0
Tel No.: (519) 661-0609
Fax No.: (519) 667-0366
Web Site: www.tekron-inc.com
Corporate Email: luigibrun@tekron-inc.com
Contact Person: Luigi Brun
Position: Chairman
COMPANY DATA
Traded Market: OTC BB¡@
Traded Symbol: TKRN¡@
Outstanding Shares: 34 million¡@
Public Float: 6 million¡@
52 Week High: $ 0.20¡@
52 Week Low: $ 0.03¡@
Present Price: Click Here¡@
INTRODUCTION
Tekron, Inc. continues its search for compatible merger and acquisition candidates, companies and technologies that can enhance and assure a steady, constant and bright future for the Company, its shareholders, management and employees. Tekron, is further committed to aggressively and diligently fulfilling its commitment of "Bringing to Market", the new and exciting technologies presently owned by or licensed to Tekron, Inc.
An experienced/specialized management group is in place and the Board assures that the organization has the vision and leadership to carry out an aggressive agenda.
TEKRON, INC. SUBSIDIARY
(1) Tekron Medical Inc.
The major investment planned by Tekron Medical Inc. is in a proposal for the further development, manufacturing and marketing of five non-invasive medical monitoring devices developed by scientists at Defence R&D Canada, which are the subject of a draft license agreement between Her Majesty the Queen (for the Minister of National Defence) and Tekron Medical.
To complete the industrial development and commercialize novel medical technologies that were conceived by applying dual-use advance sonar and radar techniques for medical imaging applications. In particular, Tekron Medical has been established to achieve the following long-term goals and objectives:
1. To provide health benefits to consumers around the world by exploiting the intellectual property rights of the innovations that define the system products listed below.
2. To provide broad exposure in an international forum and to create a showcase for non-invasive diagnostic technology advancements.
3. To build a viable Medical Technology company that will lead the international medical community in the R&D and industrial exploition of the next phase of technology trends in the areas of:
¡P Non-Invasive Vital Signs Monitoring Systems
¡P Blood pressure (continuous & discontinuous) monitoring in noisy environments
¡P 3-D Tomography Systems
¡P Cardiac imaging by CT, PET, or MRI
¡P Real time 3D (i.e. 4D) Ultrasound with high image resolution
¡P Intracranial monitoring of brain core temperature
¡P Intracranial monitoring of brain injuries, hemorrhage, tumors, stroke, and drug effects in brain.
(2) REVA Technologies Corp.
REVA Technologies Corp. has evolved as a result of concern for our environment and the air we breathe. As an effort to assist in the reduction of the air pollutants and a need to do something to improve our air quality, seven years was spent searching and developing an environmentally friendly product to take to the market. The Company has acquired the advanced technology of Canadian Electric Vehicles and developed the REVA Utility Vehicles for niche markets.
MANAGEMENT
Tekron, Inc. has a well experience management team with experience in different areas. The management team includes:
Dr. James Insell, CEO, and Chief Scientific Officer
Dr. Insell received his B.Sc. in engineering physics from the University of Waterloo in 1972. His scientific training broadened as he took positions at The Hospital for Sick Children, Sunnybrook Hospital, Toronto, Ontario and the University of Toronto, Department of Surgery, studying the ultrastructure of hyperacute rejection, human fetal lung development and extracorporeal renal viability in the laboratories of Dr. Martin Barkin, Dr. Cohen and Dr. G.A. Taylor. He pursued his electron microscopic interests studying the genetics, ultrastructure and physiology of predacious fungi, receiving his M.Sc. in microbiology in 1975 from the University of Waterloo. He earned his Ph.D. in bacteriology and immunology from the School of Medicine in 1982. In 1984, Dr. Insell took his discovery of microbial ontogenetic evolution and founded a biotechnology company commercializing this finding. For the next eight years, he developed and patented bacteria that degrade toxic waste as well as developed novel strains of the insecticidal bacteria Bacillus thuringiensis and Bacillus laterosporus and the renowned human pathogen Bacillus anthracis (anthrax). Dr. Insell took the first biotech company public in Canada. Most recently, Dr. Insell has been retained by large automotive corporations and financial institutions to provide consulting and laboratory services for the identification and countermeasure response to germ warfare agents and the response to other unidentified biohazardous materials (RUM). Dr. Insell has developed biohazard response protocols and designed an emergency responder biohazard kit (equipment) for RUM. Dr. Insell teaches these protocols to the medical staff and emergency response personnel in the automotive industry. Dr. Insell lectures on anthrax, tularemia, plague, botulinum, ricin, smallpox and other viral infections such as West Nile virus, SARS, bovine spongiformy encephalitis (mad cows disease) and their corporate response.
Luigi Brun, President
Mr. Brun enjoyed a successful career in commercial construction and property development as a key executive and President of a number of companies from 1976 until 1991. Since then, he has provided management and capital acquisition leadership for a number of start-up companies by being the catalyst in the capitalization of these corporations. He brings management skills and valued entrepreneurial foresight to REVA.
Donald Douglas, Vice President
Mr. Douglas is a professor and coordinator of the Police Foundations and Security Administration programs at Conestoga College for 27 years. Mr. Douglas recently served with the U.S. Department of Justice in police training (ICITAP) as part of the United Nations peace-keeping force in Haiti. He holds degrees from Cambridge and London University, an honours degree from Sir George Williams University and an M.A. in Sociology from McMaster University, plus he is the author of numerous articles and papers in his field. Mr. Douglas has also served as Chairperson with direct responsibility for fund-raising for many not-for-profit community service organizations.
Mary Maras, Public Relations Consultant
Ms. Maras has garnered more than 15 years of experience in public relations and marketing for a variety of industries, corporations and non-profit organizations. Her excellent communicative and organizational skills have been sharpened through her years of experience. Ms. Maras's enthusiasm for her work will help propel the Company forward. She welcomes all inquiries and is eager to assist.
NEWS UPDATE
On November 20, 2003, Tekron, inc. announced that in light of the current SARS concern in China, Biovirus is proceeding to immediately develop a putative vaccine for SARS using its mathematical ( computational genomics ) technology platform. It will either private financing or apply for a grant with the Canadian Federal government.
On November 20, 2003, Tekron, Inc. announced that Biovirus and Dr. Insell are proceeding with development of military applications of their combined technology platforms.
On November 13, 2003, Tekron, inc. is proceeding to partner and negotiate licensing for the products and technology platform of Biovirus. The Company has developed several antigens that have exhibited unique immunogenic responses to multiple herpes viruses.
On November 11, 2003, Tekron, Inc. is undertaking its due diligence of Biovirus, which is proceeding forthwith. It is expected that the deal with Biovirus will close within 30 days without any foreseeable problems. Hence, it has commenced applying for a large $30 million grant over 3 years for the Canadian subsidiary of Biovirus of which Tekron will hold a 50% interest.
On October 09, 2003, Tekron, Inc. announced the introduction of Tekron Digital Compression Software (TDCS) to the retail market. Tekron's revolutionary new software is capable of compressing data and digital photos up to 1,000 times, thus achieving faster internet transmission speeds than are currently possible. Digital photos retain their original resolution after they are received and decompressed. This process involving JPEG compression, greatly reduces the time required to send files and pictures over the Internet and provides approximately 1,000 times more storage space on music, camera video cards and discs for storage of music, video movies, files and pictures for any disc including the small camera discs that are inserted into video and still digital cameras plus 1,000 times faster transmission of video and pictures over the Internet.
On September 30, 2003, Tekron, Inc. announced that the Company will acquire Canachina Inc., a manufacturer of TV, digital set-top receivers and user application software. Both companies will trade on the Shanghai Technology Stock Exchange (STSE) and will maintain Web sites in Chinese and in English to allow customers to access a wide range of applications for digital technology, including Internet access and digital video/audio compression for high speed download. The two main technologies represent a multi-billion dollar business and will give the companies access to markets across China and Canada. The initial market will include Shanghai's 30 million residents who will be offered unrestricted Internet access via TV set-top receivers that provide a comprehensive range of advanced cable, satellite and terrestrial digital video and audio applications with interactive customer capabilities.
On September 25, 2003, Tekron, Inc. announced that the Company will begin services to execute project activities in bioremediation and environmental engineering services for private and public clients. Tekron, Inc. and Sub Surface Waste Management, Inc. (OTC BB:SSWM.OB) have signed an agreement whereby Tekron will provide SSWM with captive and referral project contracts for property redevelopment, industry and public agency compliance and government enforcement to address environmental impacts.
Disclaimer
Copyright (c) 2000 - 2004 Chinese Investment Club Inc.
All Right Reserved. Do not duplicate or redistributed in any form.
ª©Åv©Ò¦³, ¥¼¸g¦P·N, ¤£±o¥H¥ô¦ó§Î¦¡Âà¸ü©Î½¦L |
